<?xml version="1.0" encoding="UTF-8"?>
<p>Clinical evidence. 
 <italic>Polygala senega</italic> preparations have not been trialed clinically for respiratory diseases. French patent mentioned that a triterpene acid isolated from 
 <italic>P. senega</italic> possesses anti-inflammatory action (
 <xref rid="B341" ref-type="bibr">Mitchell and Rook, 1979</xref>). Another French Patent (Tubery P., Fr Demande Patent 2,202,683) claimed the fluid extract prepared with 
 <italic>P. senega</italic> could reduce the viscosity of phlegm in patients with bronchiectasis (
 <xref rid="B42" ref-type="bibr">Barnes et al., 2012</xref>). However, data on this clinical trial are limited. Overall, the clinical evidence is Low.
</p>
